National Impact
The country needs regenerative medicine to work.
Southern New Hampshire is building the infrastructure to make it possible.
What this means: building the systems, workforce, and capabilities needed to turn scientific breakthroughs into real treatments for patients.
Regenerative technologies hold the potential to change how medicine addresses conditions that have long had no effective treatment. But that potential can only be realized if the manufacturing pathway is ready, if therapies can be produced at scale, with consistency, and with a workforce prepared to sustain them.
That's the national challenge. And it's the one ReGen Valley was built to solve.
This is about ensuring the U.S. can develop, manufacture, and deliver these therapies at scale — reliably and competitively.
National stake
What it means
Competitiveness
The race to lead global regenerative medicine manufacturing is real. This region is building the capacity to win it for the U.S.
Resilience
Domestic manufacturing of regenerative technologies reduces supply chain fragility and dependence on international production.
Patient Outcomes
The faster therapies move through the manufacturing pathway, the sooner they reach the patients who need them.
Coordinated Manufacturing
Place-based ecosystems reduce friction. Density of capability combined with alignment of partners means faster time from clinical trial to delivery.
Together, these elements position the region to contribute to a stronger, more competitive national bioeconomy.
What's built in Southern New Hampshire reaches patients everywhere.
What this means: the work happening here doesn’t stay here — it scales, reaching patients, partners, and healthcare systems across the country.
Talent trained here. Technologies manufactured here. Therapies delivered nationwide.
Southern New Hampshire's strength isn't just regional pride. It's a national asset. When a region combines manufacturing infrastructure, academic depth, clinical networks, and a committed workforce, the result isn't a local success story. It's a national pipeline. And when that industry grows, the benefits move through every corner of the community, into careers, households, and futures that a thriving economy makes possible.
This creates opportunities locally while contributing to solutions that matter nationally.
Promise statement
Every investment in the ReGen Valley ecosystem is an investment in faster, more accessible regenerative therapies for patients across the country.
Investment that builds the pathway, not just the promise.
What this means: investing not just in ideas, but in the systems required to deliver real outcomes.
Designation as a Tech Hub came with something beyond recognition: the resources to build real infrastructure. The investment flowing into ReGen Valley, from public and private sources, is being deployed across the full manufacturing pathway, from workforce development to physical facilities to the coordination systems that keep everything moving.
Each investment is designed to strengthen a specific part of the pathway — so progress can move from development to delivery without unnecessary delays.
Investment area
What it builds
Workforce
Training programs, apprenticeships, and career pathways that fill the biomanufacturing pipeline at every level
Facilities
Lab and manufacturing space built and expanded for regenerative technology production
Programs
Manufacturing support, startup incubation, regulatory navigation, and commercialization resources
Coordination
The connective infrastructure that keeps 80+ partners aligned and moving
Together, these investments ensure the region has the capacity to support growth, scale innovation, and deliver results.
Coming
Numbers
The numbers that tell the story. Shared with the homepage, designed in the homepage pass.
Coming
CTA band
Help build the pathway to patients. Shared with the homepage closing CTA, designed in the homepage pass.